SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 127 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,875,000 | +19.4% | 458,943 | -3.0% | 0.14% | +18.8% |
| Q1 2016 | $5,760,000 | +38.1% | 473,273 | +80.5% | 0.12% | +37.6% |
| Q4 2015 | $4,172,000 | +29.8% | 262,204 | +25.1% | 0.08% | +28.8% |
| Q3 2015 | $3,214,000 | -27.4% | 209,646 | +15.1% | 0.07% | -17.5% |
| Q2 2015 | $4,426,000 | +40.6% | 182,071 | +34.5% | 0.08% | +45.5% |
| Q1 2015 | $3,148,000 | – | 135,403 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |